ATP7A and ovarian carcinoma: These transporters are observed to be upregulated in cisplatin-resistant cancer cells and high levels of ATP7A and ATP7B are associated with significantly poorer overall survival in patients with ovarian cancer and ovarian carcinoma, respectively [7,8].